E130-0679 Screening compound: 8-[4-(3-chlorophenyl)-5H-chromeno[4,3-d]pyrimidin-2-yl]-1,4-dioxa-8-azaspiro[4.5]decane

E130-0679 Screening compound: 8-[4-(3-chlorophenyl)-5H-chromeno[4,3-d]pyrimidin-2-yl]-1,4-dioxa-8-azaspiro[4.5]decane
E130-0679 Screening compound: 8-[4-(3-chlorophenyl)-5H-chromeno[4,3-d]pyrimidin-2-yl]-1,4-dioxa-8-azaspiro[4.5]decane alternative view

Chemical Structure Depiction of ChemDiv screening compound E130-0679
8-[4-(3-chlorophenyl)-5H-chromeno[4,3-d]pyrimidin-2-yl]-1,4-dioxa-8-azaspiro[4.5]decane

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E130-0679

Molecular Formula

C24H22ClN3O3 (C24 H22 ClN3 O3)

Compound Name

8-[4-(3-chlorophenyl)-5H-chromeno[4,3-d]pyrimidin-2-yl]-1,4-dioxa-8-azaspiro[4.5]decane

IUPAC name

8-[4-(3-chlorophenyl)-5H-chromeno[43-d]pyrimidin-2-yl]-14-dioxa-8-azaspiro[4.5]decane

SMILES

Clc1cc(-c2nc(N(CC3)CCC33OCCO3)nc-3c2COc2c3cccc2)ccc1

InChI

InChI=1S/C24H22ClN3O3/c25-17-5-3-4-16(14-17)21-19-15-29-20-7-2-1-6-18(20)22(19)27-23(26-21)28-10-8-24(9-11-28)30-12-13-31-24/h1-7,14H,8-13,15H2

InChI Key

RECBOLVPMQTVTB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14840806

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

435.91

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.164

Distribution Coefficient, logD

5.164

Water Solubility, LogSw

-5.57

Polar Surface Area

45.084

Acid Dissociation Constant (pKa)

16.68

Base Dissociation Constant (pKb)

4.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

E130-0679 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E130-0679 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E130-0679?
Check Price and Availability of E130-0679, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E130-0679 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E130-0679
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E130-0679
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E130-0679 available by request